{
  "id": 6592820,
  "title": "Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?",
  "url": "https://urgent.news/2026/09/10/which-healthcare-etf-is-the-better-buy-fidelitys-broad-fhlc-or-state-6592820",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-10T11:44:18.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/etfs/2026/09/10/which-healthcare-etf-is-the-better-buy-fidelity-s-broad-fhlc-or-state-street-s-pharma-focused-xph/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceuticals and charges significantly more for it.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?",
        "url": "https://urgent.news/2026/09/10/which-healthcare-etf-is-the-better-buy-fidelitys-broad-fhlc-or-state",
        "published": "2026-09-10T12:04:18.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}